We refer to the announcement made by the Company on 8 July 2020 (Reference Number: GA1-08072020-00011) pursuant to Paragraph 8.04 and Paragraph 2.1(e) of Practice Note 17 (“PN17”) of the Main Market Listing Requirements of Bursa (“Main LR”) (“First Announcement”).

We also refer to the announcement made by the Company on 27 May 2021 (Reference Number: GA1-27052021-00064) pursuant to Paragraph 8.04 and Paragraph 2.1(a) of PN17 of the Main LR (“Second Announcement”).

Unless otherwise defined, the definitions set out in the First Announcement and Second Announcement shall apply herein.

Pursuant to Paragraph 16 (c) of Bursa circular on Additional Relief Measures dated 16 April 2020, and Paragraph 8 (c) of Bursa circular on Additional Relief Measures dated 17 February 2021, the Company is required to re-assess its condition at the expiry of the Relief Period. In this regard, the Company wishes to announce that it continues to trigger the prescribed criteria pursuant to Paragraph 8.04 and Paragraphs 2.1(a) and 2.1 (e) of PN17 of the Main LR.

The Board of Directors also wishes to advise that the Company had submitted its application to Bursa for the Relief Period to be extended beyond 7 January 2022 and is currently awaiting for Bursa's decision.

Further announcement will be made in due course regarding the outcome of the Company’s application to Bursa for the extension of the PN17 Relief measures.

 
This announcement is dated 7 January 2022.